PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187906. A total of 3 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $77,000 | -63.0% | 205 | -50.0% | 0.00% | – |
| Q4 2019 | $208,000 | +10.1% | 410 | +9.6% | 0.00% | -100.0% |
| Q3 2019 | $189,000 | -11.7% | 374 | +7.8% | 0.00% | 0.0% |
| Q2 2019 | $214,000 | – | 347 | +34600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q4 2018 | $93,000 | -38.8% | 222 | -8.6% | 0.00% | – |
| Q3 2018 | $152,000 | -74.5% | 243 | -67.3% | 0.00% | -100.0% |
| Q2 2018 | $596,000 | +1762.5% | 742 | +146.5% | 0.00% | +100.0% |
| Q1 2018 | $32,000 | +966.7% | 301 | +126.3% | 0.00% | – |
| Q4 2017 | $3,000 | -57.1% | 133 | -5.7% | 0.00% | – |
| Q3 2017 | $7,000 | +133.3% | 141 | +29.4% | 0.00% | – |
| Q2 2017 | $3,000 | -90.0% | 109 | +45.3% | 0.00% | -100.0% |
| Q4 2016 | $30,000 | +2900.0% | 75 | +53.1% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 49 | +53.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 32 | +60.0% | 0.00% | – |
| Q1 2016 | $0 | – | 20 | -16.7% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 24 | -84.5% | 0.00% | -100.0% |
| Q2 2015 | $8,000 | – | 155 | +1837.5% | 0.00% | – |
| Q1 2015 | $0 | – | 8 | +166.7% | 0.00% | – |
| Q4 2014 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 42,300 | $261,000 | 0.00% |
| SIMPLEX TRADING, LLC | 347 | $214,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |